APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 170 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $517,344 | -74.9% | 13,600 | -39.8% | 0.00% | -75.0% |
| Q2 2023 | $2,058,860 | +73.4% | 22,600 | +25.6% | 0.00% | +100.0% |
| Q1 2023 | $1,187,280 | +58.1% | 18,000 | +63.6% | 0.00% | 0.0% |
| Q3 2022 | $751,000 | -69.9% | 11,000 | -80.1% | 0.00% | 0.0% |
| Q2 2022 | $2,493,000 | +50.7% | 55,140 | +69.4% | 0.00% | +100.0% |
| Q1 2022 | $1,654,000 | +19.1% | 32,550 | +10.9% | 0.00% | 0.0% |
| Q4 2021 | $1,389,000 | -16.2% | 29,350 | +11.9% | 0.00% | 0.0% |
| Q2 2021 | $1,658,000 | +630.4% | 26,240 | +395.1% | 0.00% | – |
| Q1 2021 | $227,000 | -25.1% | 5,300 | 0.0% | 0.00% | – |
| Q4 2020 | $303,000 | -58.4% | 5,300 | -78.0% | 0.00% | -100.0% |
| Q3 2020 | $728,000 | -15.1% | 24,120 | -8.0% | 0.00% | 0.0% |
| Q2 2020 | $857,000 | +13.8% | 26,222 | -6.8% | 0.00% | 0.0% |
| Q1 2020 | $753,000 | -19.6% | 28,122 | -8.1% | 0.00% | 0.0% |
| Q4 2019 | $937,000 | – | 30,604 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 1,114,962 | $63,776,000 | 24.13% |
| Octagon Capital Advisors LP | 548,374 | $31,367,000 | 10.87% |
| Ghost Tree Capital, LLC | 325,000 | $18,590,000 | 4.14% |
| Burrage Capital Management LLC | 81,357 | $4,654,000 | 3.55% |
| Aufman Associates Inc | 53,642 | $3,068,000 | 2.75% |
| ACUTA CAPITAL PARTNERS, LLC | 167,054 | $9,555,000 | 2.60% |
| Cormorant Asset Management, LP | 1,866,108 | $106,741,000 | 2.54% |
| Tri Locum Partners LP | 121,409 | $6,945,000 | 2.52% |
| venBio Partners LLC | 490,471 | $28,055,000 | 2.48% |
| HHLR ADVISORS, LTD. | 5,028,289 | $287,618,000 | 2.29% |